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Cytosine hydroxymethylation (5hmC) in mammalian DNA is the product of oxidation of methylated 
cytosines (5mC) by Ten-Eleven-Translocation (TET) enzymes. While it has been shown that the TETs 
influence 5mC metabolism, pluripotency and differentiation during early embryonic development, the 
functional relationship between gene expression and 5hmC in adult (somatic) stem cell differentiation 
is still unknown. Here we report that 5hmC levels undergo highly dynamic changes during adult stem 
cell differentiation from intestinal progenitors to differentiated intestinal epithelium. We profiled 5hmC 
and gene activity in purified mouse intestinal progenitors and differentiated progeny to identify 43425 
differentially hydroxymethylated regions and 5325 differentially expressed genes. These differentially 
marked regions showed both losses and gains of 5hmC after differentiation, despite lower global levels 
of 5hmC in progenitor cells. In progenitors, 5hmC did not correlate with gene transcript levels, however, 
upon differentiation the global increase in 5hmC content showed an overall positive correlation with 
gene expression level as well as prominent associations with histone modifications that typify active 
genes and enhancer elements. Our data support a gene regulatory role for 5hmC that is predominant 
over its role in controlling DNA methylation states.
Intestinal epithelium is produced when stem progenitors at the base of intestinal crypts exit from their prolif-
erative state and differentiate1. Since stem progenitors and differentiated progeny have identical genomes, their 
differential gene expression states are achieved through genome modulation by epigenetic factors. The precise 
nature of the epigenetic mechanisms involved in intestinal homeostasis are still poorly understood as are the role 
of the epigenetic modifications and the complexes that define them2–4.
Cytosine hydroxymethylation (5hmC) has been identified as the oxidation product of methylated cytosines 
(5mC) by the Ten-Eleven-Translocation enzymes (TETs)5,6. Subsequently, 5hmC and TETs (TET1, TET2 and 
TET3) have been profiled in many pluripotent and somatic cell types7–15 as well as neoplasias16–25. Consistent 
with a role in epigenetic reprogramming, the absence of TETs disrupts DNA methylation patterns26, hampers 
embryonic development27,28, impairs somatic cell transfer29 and promotes neoplasia30,31. In addition to being an 
intermediate in active DNA demethylation32, 5hmC has been shown to be a predominantly stable DNA modifi-
cation13. Within the genome, 5hmC is located at transcriptionally active genes and regulatory elements11,14 and 
chromatin associated complexes33–36.
The proliferating gut crypt progenitors, from which tumours can arise37, show reduced levels of 5hmC relative 
to the differentiated epithelium25,38–40. In this study we have mapped gene expression and 5hmC in purified stem 
progenitors and differentiated epithelium of the adult mouse intestine to identify which 5hmC-marked genes play 
a role in intestinal differentiation.
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Results and Discussion
Initially we confirmed the global levels of 5hmC by immunohistochemistry and the correlation with proliferation 
by staining with the Mki67 marker (Fig. 1a,b). Mki67 positive crypts in the proximal and distal small intestine 
(SI) showed lower levels of 5hmC relative to the Mki67 negative villi and crypt Paneth cells as well as cells within 
the stroma (Fig. 1a,b). The negative correlation between 5hmC and Mki67 was also observed in mouse colon and 
ApcMin41 SI adenomas (Supplementary Fig. S1). Staining for 5mC showed equal levels in crypts, villi and stroma. 
These results confirm previous observations in mouse and human normal and neoplastic colon17,25.
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Figure 1. 5hmC is low in the proliferating gut crypt progenitors and increased in the differentiated villus 
epithelium of the mouse small intestine (SI). (a) Immunohistochemistry for Mki67, 5hmC and 5mC in the 
mouse proximal and distal small intestine (SI). Horizontal bars = 20 um. (b) Detail for the crypts in the distal 
SI. The asterisk indicates the transient amplifying zone positive for Mki67 and low for 5hmC. The negative 
correlation between Mki67 and 5hmC is also observed for the crypt base columnar cells (arrowheads) and the 
Paneth cells (arrows). Methylation levels do not appear to differ between these cell populations. A negative 
correlation between Mki67 and 5hmC was also observed in the colon and ApcMin small intestinal adenomas 
(Supplementary Figure S1). (c) Flow cytometry dot plot for the Cd24a_Mid and Cd24a_Neg populations. 
Ulex-lectin was used to deplete differentiated Paneth and Goblet cells and Cd45 to remove hematopoietic cells. 
(d) The genomic profiles of 5hmC and how they may correlate with gene activity upon gut differentiation were 
assessed by profiling expresssion (RNA-seq) and 5hmC (hmeDIP-seq) of the purified crypt stem progenitors 
(Cd24a_Mid) and differentiated villi (Cd24a_Neg).
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We then used the Cd24a cell surface marker and flow cytometry to purify stem progenitors (Cd24a_Mid) and 
differentiated cells (Cd24a_Neg) (Fig. 1c). The Cd24a_Mid (low) expressors have previously been shown to carry 
pluripotency potential42. Here we further purified Cd24a_Mid and Neg populations by including Ulex-lectin and 
Cd45 to remove Paneth/Goblet cells and hematopoietic cells respectively as previously described43. Aliquots of 
Cd24a_Mid (progenitors) and Cd24a_Neg (differentiated progeny) populations were used to isolate total RNA 
to measure gene expression by poly-A mRNA-seq and genomic DNA to map 5hmC by hmeDIP-seq (Fig. 1d).
RNA-seq showed 2694 and 2631 genes that were significantly up and downregulated respectively with an 
adjusted p value (p.adj) < 0.001 in differentiated cells (Fig. 2 and Supplementary Tables S1 and S2). Unsupervised 
hierarchical clustering clearly separated the two cell types (Fig. 2a) and expression changes included gain of dif-
ferentiation markers Villin1 (Vil1) and Mucin2 (Muc2) and loss of stem cell marker Musashi 1 (Msi1) (Fig. 2b). 
In agreement with reduced protein expression, Cd24a and Mki67 transcripts were strongly reduced in the 
Cd24_Neg cells (Fig. 2b). The Paneth cell marker Defensin alpha 5 (Defa5) was not significantly increased in 
Cd24a_Negs (Fig. 2b) as expected from Paneth cell depletion with Ulex-lectin. These loci were validated by 
qRT-PCR (Supplementary Fig. S2). High concordance was also observed for significantly downregulated genes 
in Cd24a_Neg cells, i.e. stem progenitor specific, with loci recently shown to mark intestinal stem cells by mass 
spectrometry and the Lgr5 stem cell factor44 (Fig. 2c and Supplementary Table S3). Moreover, marked reduction 
of Myelocytomatosis oncogene (Myc) and increased levels of Transducer of ErbB-2.1 (Tob1) (Fig. 2d) support Wnt 
pathway inhibition and Bmp pathway activation, respectively, that characterizes differentiation of the adult intes-
tine1. These results confirm that the purification strategy can robustly separate stem progenitors from differenti-
ated cells, and provide a powerful resource for future analyses.
Figure 2. RNA-seq. The intestinal stem cell signature and behaviour of epigenetic factors. (a) Cluster 
heatmap for loci with a statistically significant change (adjusted p value < 0.001) in gene expression of the four 
samples analysed. (b) MA scatter plot for expression change in Cd24a_Neg relative to Cd24a_Mid cells. Blue 
background represents all genes overlaid by significantly upregulated (dark grey) and downregulated (light 
grey) genes. Also overlaid are differentiation-markers Villin1 (Vil1) and Mucin2 (Muc2), stem cell marker 
Musashi1 (Msi1) and Cd24a, Tet1–3 hydroxylases, B2m microglobulin ‘housekeeper’, Paneth-cell marker 
Defensin alpha 5 (Defa5) and proliferation marker Mki67. (c) Gene expression change in Cd24a populations 
compared to the intestinal stem cell (ISC) signature derived from mass spectrometry analysis of Lgr5-GFP 
mice (Lgr5-MS-ISC, Muñoz et al. – listed in Supplementary Table S3). (d) Browser shot for RNA-seq reads 
levels in Myelocytomatosis oncogene - Myc (−3.4 log2 fold, p.adj = 1.4e-48) and Transducer of ErbB-2.1 - Tob1 
(1.3 log2 fold, p.adj = 5.3e-11). (e) Top gene ontology categories unique for Up or Down regulated genes (See 
Supplementary Fig. 4 for extended display of GO categories). (f) Venn plots for RNA and DNA binding factors 
as well as collated epigenetic factors (listed in Supplementary Tables S6-S8). (g) MA scatter plot for expression 
change in Cd24a_Neg relative to Cd24a_Mid cells. Blue background represents all genes overlaid by selected 
epigenetic factors. Circle sizes are the inverse log of the adjusted p value (smaller p-values produce larger 
circles). As reference, padj for Uhrf1 is 6.4e-68 whereas Mll1 is at 3.9e-02. Triangles indicate a p value > 0.05.
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Remarkably, changes in Tets transcripts levels were moderate and did not always mirror the increase in global 
levels of 5hmC upon differentiation, similar to our pervious observations for reduced 5hmC in human colon 
neoplasia25. Tet1 levels were low in Cd24a_Mid progenitors and went down with differentiation, Tet2 was reason-
ably abundant in progenitors with a mild increase in differentiated progeny and Tet3 the most abundant of the 
Tets with levels maintained in the Cd24a_Neg differentiated cells (Fig. 2 and Supplementary Fig. S2). Our results 
in this regard appear to differ from other published studies39,40. Although Kim et al.39 also observed a marked 
reduction of Tet1 upon differentiation, they showed that Tet1 was the most abundant of Tets. This difference may 
be due to the alternative stem cell purification approach. Chapman et al. showed that TET1 expression increases 
upon in vitro colonocyte differentiation40. This disagrees with our study and that of Kim et al. and may be due to 
species-specific differences or cell culture effects.
We additionally observed no alternative exon usage for Tet2 or Tet3 between Cd24a_Mid and Cd24a_Neg cells 
(Supplementary Fig. S3) suggesting that oxygenase activity in the progenitors and differentiated cells might be 
regulated by post-transcriptional events45–49.
Goseq50 analyses of the differentially expressed genes in progeny and pluripotent cells (Supplementary 
Tables S4 and S5) showed that upregulated genes enriched for gene ontology (GO) categories involved in cellu-
lar metabolic functions localized to the cytoplasm whereas downregulated loci enriched for RNA binding fac-
tors and nucleic acid metabolic processes within the nucleus (Fig. 2e and Supplementary Fig. S4). These GO 
profiles are consistent with enrichment of enterocytes in the Cd24a_Negs and enrichment of proliferating stem 
progenitors in the Cd24a_Mid cells. The RNA binders (GO:0003723) include the stem cell marker MSI1 but 
also methyl-CpG binding factor MECP2, that also directly interacts with DNA51. Mecp2 was significantly down-
regulated in Cd24a_Neg cells (p.adj = 2.4e-03, Supplementary Table S6) but with overall low levels as recently 
described52. The DNA binding category (GO:0003677) was also significantly enriched in genes downregulated in 
Cd24_Neg cells (p.adj = 1.5e-16, Supplementary Table S7 and Fig. 2f).
To further focus the analysis on epigenetic factors that establish, recognize or erase epigenetic modifica-
tions, many of which are not classified as nucleic acid binders, we collated epigenetic modifiers and interactors 
(Supplementary Table S8)53,54. Again, we observed a strong bias towards downregulation of these loci (Fig. 2f 
bottom). Notably, key factors involved in methylation of DNA (Uhrf1, Dnmt1, Dnmt3b) and histones (Suv39h – 
H3K9, Ezh2 – H3K27, Suz12 – H3K27, Whsc1 – H3K36, Mll1 – H3K4) were downregulated whereas most factors 
involved in demethylation of DNA and histones were either moderately upregulated (Tet2, Tet3 – 5mC, Kdm4b 
– H3K36, Kdm5b – H3K4, Kdm6b – H3K27) or their levels maintained (Kdm1a – H3K4, Kdm6a – H3K27)
(Fig. 2g). Two exceptions were Tet1 that was downregulated from an already low level in progenitors and mild 
downregulation of Kdm2b, a histone H3K4 and K36 demethylase that binds CpG islands of early lineage genes 
in mouse embryonic stem cells55,56. Crebbp and Hdac3, encoding for enzymes that acetylate and deacetylate his-
tone H3 lysine 27 respectively57, were abundant and maintained throughout differentiation. This may indicate 
that levels of H3K27ac, a mark of enhancer elements58, are maintained throughout differentiation. Although 
post-transcriptional events influencing the stability or activity of epigenetic factors cannot be discerned by 
RNA-seq, these results show that intestinal differentiation involves a complex balance in the levels of a consider-
able number of epigenetic factors (Supplementary Table S8).
Next, we profiled 5hmC by hmeDIP-seq in four samples matched to those used in RNA-seq plus one addi-
tional pair. Cluster analysis using affinity values (reads in peaks) by DiffBind59 showed a clear separation between 
the Cd24a_Mid and Neg samples together with increased affinity in the Cd24a_Neg cells (Fig. 3a), in line with the 
global increase of 5hmC levels upon differentiation. Notably however, when we used an adjusted p value of 0.001, 
we obtained a roughly equal number of peaks that gained or lost 5hmC (21858 and 21567 peaks respectively out 
of 97309 peaks identified) (Fig. 3b, Supplementary Tables S9 and S10). Peak annotation and visualization (PAVIS) 
analysis60 showed that ~60% of peaks were intragenic, mainly within introns, but statistically significant enrich-
ments in exons (p < 1.00e-200) and 3′UTRs (p < 1.00e-15) were obtained. The remaining ~40% of 5hmC peaks 
were intergenic of which ~5% were within 5 kb of the transcription start sites – TSS) (Fig. 3c). Gain of 5hmC 
during differentiation mainly occurred inside genes, both at introns and within exons, with 5hmC loss more 
frequent at distant intergenic sites (>5 kb upstream of TSS or >1 kb downstream of TTS) (Fig. 3c,d). Myc had 
loss and Tob1 gain of 5hmC within the gene body and upstream intergenic regions (Fig. 3e and Supplementary 
Fig. S5), showing that 5hmC change and gene expression change (Fig. 2d) at these loci were positively correlated.
Immunoprecipitation sequencing for DNA modifications has been reported to be intrinsically enriched 
for short tandem repeats (STRs) due to non-specific antibody binding affinity61. An IgG-only control was not 
included in our experimental design. The DNA pull-down conditions are identical for Cd24a_Mid and Neg cells 
and thus it would be assumed that non-specific sequences are unlikely to be statistically significantly different 
between the two conditions. With this in mind we conducted a motif discovery analysis (MEME-ChIP62) to assess 
sequence contents in peaks that gained or lost 5hmC in progeny. Given the peak size and p value cut-off used 
to select peaks with 5hmC change (Supplementary Fig. S6) the analysis showed CpG-dinucleotide-containing 
motifs emerged from loci that gained 5hmC and CA repeat sequences predominant at regions with 5hmC loss. 
This could suggest that immunoprecipitation for 5hmC enriches for STRs when 5hmC is in low abundance. 
However, intersection of 5hmC peak intervals with (CA)n simple repeat intervals showed the repeats are more 
abundant in peaks with 5hmC loss (8.3% in loss versus 3.7% in gain of all 5hmC peaks identified; Supplementary 
Fig. S6). CA repeat sequences can occur adjacent to CpG rich sequences and have been shown to play a role in 
regulating dynamic changes in 5hmC and DNA methylation during differentiation63. Moreover, the contribution 
of non-specific antibody activity (measured as abundance of STRs) is also relatively low. We therefore did not 
filter our data to remove CA repeats.
To integrate our 5hmC maps with epigenomic features involved in gene regulation we analysed the overlap 
of 5hmC peaks with genomic profiles of histone modifications. Since our flow sort material was insufficient to 
conduct ChIP measurements we used whole small intestine ENCODE ChIP-seq data. In this manner 5hmC 
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dynamics would be measured within ‘static’ histone modification intervals to assess an overall ‘interaction’. We 
observed an overlap with histone H3 lysine 36 trimethylation (H3K36me3) peaks, that marks actively transcribed 
genes57 primarily for intragenic peaks that gain 5hmC (Fig. 3f). A much greater overlap was found between 
H3K4me1 peaks and those that gain 5hmC at intergenic sites, and a considerable overlap was also observed with 
gain of 5hmC in intragenic regions (Fig. 3f). H3K27ac and bivalent H3K4me1/H3K27ac sites also often over-
lapped with 5hmC peaks, most frequently with intragenic and intergenic sites that gained 5hmC. These results 
are in good agreement with enrichment of 5hmC at poised and active enhancers recently described in mouse 
embryonic and somatic cells10,11.
Low frequency overlaps with H3K4me3 peaks were observed (Fig. 3f). This was expected given that H3K4me3 
locates mostly to transcriptional start sites (TSS) and promoter CpG islands where 5hmC is normally absent25. 
H3K27me3 and bivalent H3K4/K27me3 sites also showed a minimal overlap with 5hmC. However, genes with 
promoters marked by H3K4me3 within 5 kb of the TSS (n = 11104) were for the most part highly expressed 
in Cd24a_Mid and Cd24a_Neg cells and more frequently gained 5hmC (n = 3130, ~28%), albeit a consider-
able number lost 5hmC (n = 1477, ~13%) at the cut-off used for significant changes in 5hmC (p.adj < 0.001) 
(Supplementary Fig. S7). On the other hand, genes with bivalent H3K4/K27me3 promoters (n = 3384 promot-
ers) showed constitutively lower levels of gene activity and more frequently loss of intragenic 5hmC (~23% gain 
against ~10% loss of intragenic 5hmC) in the differentiated progeny (Supplementary Fig. S7).
Only a small number of 5hmC peaks were found to overlap with CTCF, a chromatin associated factor involved 
in long-range genetic interactions64 (Fig. 3f). ENCODE ChIP-seq profiled whole intestine, precluding resolution 
Figure 3. Dynamic behaviour of 5hmC across the genome. (a) Correlation heatmap using affinity values (reads 
in peaks) from ‘DiffBind’. Clustering of the individual samples (four of which are paired to RNA-seq data) 
was obtained as well as an increased signal for the Cd24a_Neg cells consistent with the increased global level 
observed by IHC (Fig. 1). (b) MA scatter plot for the fold change in 5hmC content in Cd24a_Neg cells relative 
to Cd24a_Mid. 21858 peaks showed gain (dark grey) and 21567 loss (light grey) of 5hmC with an adjusted p 
value < 0.001 for the change across the sample set. The blue background is the density scatter plot for all peaks 
identified (n = 97309). (c) 5hmC contents in genomic features (PAVIS analysis). (d) Boxplot for the fold change 
in 5hmC content at intragenic and intergenic peaks. (e) IGV browser shot of 5hmC enrichment profiles for 
Myc and Tob1 in Cd24a_Neg and Cd24a_Mid cells. The bigWig files represent a merge of reads from each 
Cd24a population (n = 4). P.fold is the peak fold change (log2) in hmeDIP-seq read content (normalized to 
inputs). The bar heights are proportional to the magnitude of loss (in light grey) or gain (in dark grey) in 5hmC 
content. Shown are peaks with an adjusted p value < 0.001. Orange bars are the CpG islands from the UCSC 
annotation. The window size for Myc and Tob1 is 15 kb. Please see Supplementary Figure S5 for an extended 
100 kb window). (f) Heatmap summarising the overlap between 5hmC peaks and ChIP-seq peaks for histone 
modifications, POL2 and CTCF from mouse whole small intestine (ENCODE). (g) Gene ontology analysis 
for genes associated with 5hmC change inside (intragenic) or outside (intergenic) the gene body. Shown are 
categories that are unique to each condition (Supplementary Fig. S8 shows a more extended display of GO 
categories).
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of stem cell specific signatures such as histone bivalency at promoters and enhancers. Nevertheless, these results 
identify negative and positive associations between 5hmC changes and key histone modifications.
GO analysis for genes with significant 5hmC intragenic changes (Supplementary Tables S11 and S12) 
showed enrichments of GO categories associated with cellular metabolism and cell-cell interaction (Fig. 3g and 
Supplementary Fig. S8) akin with GO category enrichments associated with upregulated genes. However, GO 
category enrichments driven by these intragenic 5hmC changes were similar for genes that gained or lost 5hmC. 
Intergenic 5hmC peaks were assigned to the nearest gene and included the proximal promoters. We observed 
enrichments for GO categories associated with cell signaling, DNA template processes and organ morphogenesis 
(Fig. 3g and Supplementary Fig. S8) – again irrespective of the direction in 5hmC change (Supplementary Fig. S8 
and Supplementary Tables S13 and S14) and in this instance akin with GO category enrichments associated 
with downregulated genes (Supplementary Fig. S4). These GO analyses would suggest that stemness in mouse 
intestine may be primarily controlled by intergenic regulatory elements and suggest that while gene activation 
or silencing is associated with changes in 5hmC, these changes are dependent on the genomic context and not 
strictly directional.
We therefore took a closer look at the association between gene expression and 5hmC genomic contexts. In 
the progenitors (Cd24a_Mid) we observed no correlation between expression levels and 5hmC for both intra-
genic and intergenic 5hmC peaks (Fig. 4a). The correlation coefficient became positive when expression level and 
5hmC content were compared in progeny (Cd24a_Neg), but more so for loci with significant changes in expres-
sion and 5hmC between progenitors and progeny (Fig. 4b). This analysis indicated that the gene expression pro-
gramme of proliferating progenitors (stem cells) does not require high levels of 5hmC and suggested a stronger 
association between expression change and 5hmC change upon lineage inductions.
The correlation coefficients rose further when the fold changes in expression were compared to the fold 
changes in 5hmC (Fig. 4c). For intragenic 5hmC peaks, comparison of significant fold changes in expression 
estimates per gene (this is the sum of reads for all annotated transcripts of a gene), with significant fold changes 
in 5hmC contents of all intragenic peaks per gene showed an overall positive but moderate correlation (r = 0.57 
for p.adj < 0.001 in expression and 5hmC change) (Fig. 4c). In agreement with GO analysis for 5hmC enrich-
ments described above, upregulated and downregulated expression could be accompanied by either gain or loss 
of 5hmC. Increasing the significance cutoff for 5hmC changes to an adjusted p value of 5.4e-20 (this is the mean 
of adjusted p values for loci with an absolute log2 fold change greater than 2) did not greatly affect the correlation 
coefficient (r = 0.55) (Fig. 4c). It is worth highlighting here that the correlation coefficients may be underesti-
mated given that poly-A enrichment depletes intronic transcripts where 5hmC is considerably enriched (Fig. 3c). 
Nevertheless, at the stringent p value the large majority of genes showed a positive correlation between expression 
change and intragenic 5hmC change, i.e. expression Up with 5hmC Up (eUp-hUp) or expression Down with 
5hmC Down (eDown-hDown) (1034 out of 1169 genes, 88.5%, Fig. 4d). Ten percent of genes (118 out of 1169) 
showed a negative correlation between expression and 5hmC change (i.e. eUp-hDown and eDown-hUp), and a 
small number of genes (~1.5%, 17 out of 1169) showed expression change in one direction with 5hmC changes in 
both directions (i.e. eUp-hUpDown and eDown-hUpDown) (Fig. 4d).
A similar behaviour was observed for the correlation between gene expression change and 5hmC change at 
intergenic peaks (Fig. 4c) albeit that the number of significant changes in 5hmC was smaller and correlation coef-
ficients weaker. Nevertheless, the proportions of genes with positive, negative and mixed correlations (85%, 14% 
and 1% respectively, Fig. 4d) were similar to those observed for intragenic 5hmC changes.
Collectively, these results reinforce previous observations of the preferential association of 5hmC with active 
loci, but also highlight that 5hmC may associate with repressor65 or activator34 activities. In this regard, two addi-
tional observations are relevant. First, genes with very low (no) expression had considerable levels of 5hmC in 
progenitors, and the 5hmC levels were significantly reduced upon differentiation, whereas genes with undetected 
5hmC showed low levels of expression in both progenitors and differentiated cells (Supplementary Fig. S9). This 
contrasts with active and 5hmC enriched genes in progenitors where the levels of 5hmC and expression are 
increased in differentiated cells (Supplementary Fig. S9). Second, we noted that higher levels of 5hmC in the 
proximal promoter associated with a lower level of activity (Supplementary Fig. S10), in agreement with recent 
reports in mouse and human ES cells66,67 and human colon25.
These results show that highly repressed genes can contain 5hmC but contrary to active genes 5hmC goes 
down with differentiation, and that genes lacking 5hmC have constitutively low levels of expression. Thus pres-
ence of 5hmC in progenitors and further accumulation in progeny would appear to be necessary for the re-tuning 
of gene expression states in differentiation of the adult intestinal epithelium. This assumption, that requires exper-
imental confirmation, would be supported by hampered embryonic development and off track lineage commit-
ment of mouse ES cells in the absence of TETs28.
Conclusions
Here we confirm a global increase in 5hmC occurs from the stem progenitors to the differentiated progeny in 
mouse small intestinal epithelium17. Importantly, despite the rise in global levels, we show that 5hmC is highly 
dynamic with prominent gains and losses across the genome of differentiated progeny. The dynamic behaviour of 
5hmC is in stark contrast with the evidence of a remarkably stable methylome during intestinal differentiation68. 
In this context, our results suggest that for the most part 5hmC would not act to control DNA methylation states. 
Conversely, given the prominent association of 5hmC with histone modifications of active loci and enhancer 
elements, our results suggest 5hmC may be primarily involved in controlling gene activity. These data provide 
a valuable resource for future mechanistic insights into the association of DNA modifications and gene activity.
Recent reports have also indicated that broadly permissive chromatin structures typify differentiation 
of the small intestine and that the phenotypic changes are primarily driven by transcription factor activi-
ties4,69. These reports question the function of the global changes in epigenetic modifications observed upon 
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Figure 4. Gene expression and 5hmC in progenitors (Cd24a_Mid) and progeny (Cd24a_Neg). (a) Correlation 
between expression levels and 5hmC content at intragenic or intergenic peaks in the Cd24a_Mid progenitors. 
Blue are all loci, black are loci with an adjusted p value < 0.001 for expression and 5hmC change between 
progenitors and progeny. (b) As in (a) but for the Cd24a_Neg progeny. (c) Correlation between the fold change 
in expression and the fold change in 5hmC content from progenitors to progeny at intragenic or intergenic 
peaks. The blue background represents all loci, the black overlay are loci with an adjusted p-value < 0.001 for the 
change in expression and 5hmC content. The red overlay are loci with and adusted p value < 5.4e-20 for 5hmC 
change (this is the mean of adjusted p values for loci with an absolute log2 fold change > 2). (d) Venn diagram 
intersecting gene symbols in the four populations at the stringent p value showing that genes (open numbers) 
that gain or lose expression (eUp or eDown respectively) can contain peaks (n in brackets) with only gain, only 
loss or gain and loss of 5hmC (hUp, hDown or hUpDown respectively).
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differentiation2,17,38. We have recently shown that rapidly cycling cells show a delay in the generation of 5hmC, 
and that once established it is very stable13. Our data suggest that this may also hold true for histone modifica-
tions, given the inverse correlations between levels of modifiers with levels of the modifications (e.g. downregu-
lation of Ezh2 with a rise in H3K27me3).
Our data highlight pronounced changes in epigenetic factors in mouse small intestinal differentiation. 
Whether these changes follow or instruct intestinal differentiation, or both, remains largely unknown. However, 
orchestrated targeting of epigenetic complexes in intestinal neoplasia70,71 suggests epigenetic factors would 
strongly influence the functional outputs of transcription factor activities.
Materials and Methods
Animals. Intestinal tissue was obtained from C57BL6/J and ApcMin mice that were housed and bred in the 
Cancer Research UK Cambridge Institute Biological Resource Unit (CRUK-CI BRU) in compliance with the stat-
utes of the Animals (Scientific Procedures) Act, 1986, UK Home office guidelines and approved by the University 
of Cambridge Animal Welfare and Ethical Review Body.
IHC. IHC was conducted in the Histopathology core facility at the CRUK Cambridge Institute. The IHC 
protocol for Rabbit anti-5hmC polyclonal (Active Motif, 39791), Mouse anti-5mC monoclonal (Diagenode, 
MAb-006) and Rat anti-Mki67 monoclonal (Dako, M7249) was previously described13. Slides were 
scanned onto an Aperio scanner for analysis. Antibodies go through a strict validation pipeline including 
a no primary antibody control staining to ensure secondary antibodies do not cross react with the tissue 
(Supplementary Fig. S11).
Intestinal epithelium fractionation and flow sort. Mouse intestinal epithelium was obtained by EDTA 
based fractionation as previously described43. Single cell suspensions of the whole small intestinal denuded epi-
thelium were sorted into Cd24a-Mid_Cd45-negative_UEA-1-negative and Cd24a-Negative_CD45-negative_
UEA-1-negative populations using Pacific blue conjugated Rat anti-CD24 (Biolegend, M1/69, 5 μL/106 cells), 
Alexa647 conjugated Rat anti-CD45 (BD Pharmingen, Cat. No. 557683, 1:200) and Atto-488 conjugated UEA-1 
(ULEX) (Sigma, 10 μL/106 cells) on a FACSAria (BD Biosciences) flow cytometer.
RNA-seq. Total RNA was extracted with the miRNeasy kit (Qiagen) following manufacturer instructions. 
Total RNA from four Cd24a_Mid and four Cd24a_Neg samples were submitted for library preparation by the 
CI-genomics core facility using the TruSeq RNA Sample Preparation Kit (Illumina). Barcoded samples were 
sequenced on a single lane of Illumina HiSeq to a depth of more than 200 million paired end (PE) 100-based pair 
(BP) reads. After demultiplexing, this yielded between 17.7–26.5 million PE reads per sample. These reads were 
trimmed to 50BP and aligned to mouse transcriptome version NCBIM37.67 using Bowtie version 0.12.872. Gene 
read counts were then derived using the MMSeq73 workflow. Differential gene expression analysis was carried 
out on these read counts using the Bioconductor package DESeq74. DEXSeq package75 was used to quantify reads 
within intervals obtained from Ensembl NCBIM37.67 gtf.
hmeDIP-seq. Genomic DNA was obtained by phenol chloroform extraction and sonicated with a Bioruptor 
(Diagenode) to an average fragment size of 500 bp. The 5hmC pulldown was performed as recently described25 
using protein G magnetic beads (LifeTechnologies) bound with 5hmC rabbit polyclonal antibody (Active Motif, 
39791) and 2 micrograms of adapter modified barcoded genomic DNA (TruSeq, Illumina). Illumina sequencing 
reads were demultiplexed and aligned against the mm9 genome assembly using BWA. Quality metrics of the 
hmeDIP-seq enrichments were obtained with ChIPQC76. DiffBind package59 was used to quantitatively compare 
reads within peak sets obtained with MACS and differential affinity with the edgeR workflow after read counts 
from input DNA were subtracted. Mean read coverage around TSS was calculated using ‘GenomicRanges’ and 
‘Rsamtools’ (Bioconductor); read coverage was normalized per million mapped reads, subtracted from input and 
mean TSS coverage plotted. Feature Enrichment analysis used the PAVIS online tool60. Summary statistics for 
hmeDIP-seq reads are in Supplementary Table S15).
Gene ontology. The goseq package50 was used for gene ontology analyses of RNA-seq and hmeDIP-seq data.
MEME-ChIP. Motif analysis of hmeDIP-seq peaks was performed using the online tool with default parame-
ters. The primary sequences within selected peaks were obtained with bedtools.
CA repeat overlaps. The (CA)n Simple_repeat intervals were extracted from the UCSC RepeatMasker table. 
Intersection of 5hmC peaks intervals with (CA)n repeat intervals was conducted using bedtools. The (CA)n 
repeats had to be fully contained within 5hmC peaks (i.e. F = 1).
qRT-PCR. 1 microgram total RNA was treated with 1U DNaseI (Promega 9PMIM610) and cDNA prepared 
with SuperscriptIII reverse transcriptase (Invitrogen) and random primers. Targets were quantified with 1x Fast 
Sybr (ABI) and 1x Quantitect assays (Qiagen) or Taqman assays by the delta CT method using B2m as normalizer 
(Supplementary Table S16).
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